Consent for Use of Stored Patient Specimens for Future Testing

Description

The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.

Conditions

HIV Infections

Study Overview

Study Details

Study overview

The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.

Plan for Obtaining Informed Consent to Use Stored Human Biological Materials (HBM) for Currently Unspecified Analyses

Consent for Use of Stored Patient Specimens for Future Testing

Condition
HIV Infections
Intervention / Treatment

-

Contacts and Locations

Los Angeles

Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States, 900331079

Los Angeles

Charles Drew Medical Center, Los Angeles, California, United States, 90059

Los Angeles

UCLA CARE Ctr, Los Angeles, California, United States, 90095

San Diego

Univ of California, San Diego, San Diego, California, United States, 92103

San Francisco

Univ of California San Francisco, San Francisco, California, United States, 94110

Stanford

San Mateo AIDS Program / Stanford Univ, Stanford, California, United States, 943055107

Stanford

Stanford Univ Med Ctr, Stanford, California, United States, 943055107

Stanford

Willow Clinic / Stanford Univ, Stanford, California, United States, 94305

Torrance

Harbor General/UCLA, Torrance, California, United States, 90502

Denver

Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States, 80262

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Parent or guardian willing to give informed consent, if applicable
  • * Either currently participating in or have ever participated in an AACTG clinical trial

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections,

David W. Haas, MD, STUDY_CHAIR, Vanderbilt University Medical Center

Study Record Dates

2027-12-31